Authors: FUJIWARA Y TAKAHASHI T YAMAKIDO M OHUNE T TSUYA T EGORIN MJ

Citation: Y. Fujiwara et al., PREDICTION OF CARBOPLATIN CLEARANCE FROM STANDARD MORPHOLOGICAL AND BIOLOGICAL PATIENT CHARACTERISTICS, Journal of the National Cancer Institute, 89(3), 1997, pp. 260-261

Authors: MIYAZAKI M FUJIWARA Y TAKAHASHI T ISOBE T OHUNE T TSUYA T YAMAKIDO M

Citation: M. Miyazaki et al., LIMITED-SAMPLING MODELS FOR ESTIMATION OF THE CARBOPLATIN AREA-UNDER-THE-CURVE, Anticancer research, 17(6D), 1997, pp. 4571-4575

Authors: MAEDA Y KONISHI T OMODA K TAKEDA Y FUKUHARA S FUKUZAWA M OHUNE T TSUYA T TSUKIAI S

Citation: Y. Maeda et al., INHIBITION OF THEOPHYLLINE METABOLISM BY ACYCLOVIR, Biological & pharmaceutical bulletin, 19(12), 1996, pp. 1591-1595

Authors: FUJIWARA Y OHUNE T OKUSAKI K NIITANI K SUMIYOSHI H TAKEMOTO Y YAMAOKA N YAMAKIDO M

Citation: Y. Fujiwara et al., BIOAVAILABILITY OF 50 AND 75-MG ORAL ETOPOSIDE IN LUNG-CANCER PATIENTS, Cancer chemotherapy and pharmacology, 37(4), 1996, pp. 327-331

Authors: SUMIYOSHI H FUJIWARA Y OHUNE T YAMAOKA N TAMURA K YAMAKIDO M

Citation: H. Sumiyoshi et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF IRINOTECAN (CPT-11) AND ITS ACTIVE METABOLITE (SN-38) IN HUMAN PLASMA, Journal of chromatography B. Biomedical applications, 670(2), 1995, pp. 309-316

Authors: OHUNE T FUJIWARA Y SUMIYOSHI H YAMAOKA N YAMAKIDO M

Citation: T. Ohune et al., PHASE-I STUDY AND CLINICAL PHARMACOLOGICAL EVALUATION OF DAILY ORAL ETOPOSIDE COMBINED WITH CARBOPLATIN IN PATIENTS WITH LUNG-CANCER, Japanese journal of cancer research, 86(5), 1995, pp. 490-500